Exclusive: Cancer drugmaker Tesaro attracts takeover interest - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Leerink Partners Downgrades Tesaro (TSRO) to Market Perform
February 10, 2017 6:51 AM ESTLeerink Partners downgraded Tesaro (NASDAQ: TSRO) from Outperform to Market Perform with a price target of $186.00 (from $152.00).
For an analyst ratings summary and ratings history on Tesaro click here. For more ratings news on Tesaro click here.
Shares of Tesaro closed at $186.91 yesterday.
... MoreTESARO (TSRO) may be worth $250/share in sale, Bloomberg citing SunTrust
February 8, 2017 1:07 PM ESTTESARO (NASDAQ: TSRO) may be worth $250/share in sale, Bloomberg citing SunTrust.
... More